Results 281 to 290 of about 337,810 (339)
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner+15 more
wiley +1 more source
Comprehensive synthesis and anticoagulant evaluation of a diverse fucoidan library. [PDF]
Chen SC+10 more
europepmc +1 more source
Clinical characteristics and long‐term outcomes in patients with apical hypertrophic cardiomyopathy
Abstract Aims As a special type of hypertrophic cardiomyopathy (HCM), apical HCM (ApHCM) has different clinical characteristics while its nature history and prognosis are not well recognized. We aimed to describe the characteristics and outcomes of ApHCM and identify predictors of adverse outcomes.
Meng Guo+3 more
wiley +1 more source
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna+18 more
wiley +1 more source
Promucetin, a new C-type lectin-like protein modulates coagulation by activating platelets via GPIb. [PDF]
Yu XQ, Zhang QY, Zhou ST, Lu QY, Sun QY.
europepmc +1 more source
Our study examined the real‐world implementation of guideline‐directed medical therapy (GDMT) and its association with mortality and hospitalization in 46 816 patients with heart failure with reduced ejection fraction (HFrEF) from the Danish Heart Failure Registry (2008–2022).
Inge Schjødt+5 more
wiley +1 more source
Oral Anticoagulation Therapy: An Update on Usage and Costs in the Endemic COVID-19 Era. [PDF]
Favaloro EJ, Pasalic L, Lippi G.
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai+4 more
wiley +1 more source
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi+21 more
wiley +1 more source